Source: BioPortfolio

GP Pharm: GP Pharm SA Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12032018 Prices from USD $250

SummaryGP Pharm SA GP Pharm is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company's product portfolio includes injectable dosage forms for the treatment of advanced prostate cancer; nocturnal...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Berta Ponsati's photo - CEO of GP Pharm

CEO

Berta Ponsati

CEO Approval Rating

90/100



GP Pharm is headquartered in Hospitalet De Llobregat, Barcelona. Berta Ponsati is the CEO of GP Pharm. GP Pharm has 2 followers on Owler.